Astera Labs Statistics
Total Valuation
Astera Labs has a market cap or net worth of $38.77 billion. The enterprise value is $37.44 billion.
| Market Cap | 38.77B |
| Enterprise Value | 37.44B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astera Labs has 174.78 million shares outstanding. The number of shares has increased by 4.73% in one year.
| Current Share Class | 174.78M |
| Shares Outstanding | 174.78M |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 9.80% |
| Owned by Institutions (%) | 70.92% |
| Float | 157.31M |
Valuation Ratios
The trailing PE ratio is 87.54 and the forward PE ratio is 32.25. Astera Labs's PEG ratio is 0.54.
| PE Ratio | 87.54 |
| Forward PE | 32.25 |
| PS Ratio | 24.91 |
| Forward PS | 12.06 |
| PB Ratio | 19.39 |
| P/TBV Ratio | 20.32 |
| P/FCF Ratio | 112.48 |
| P/OCF Ratio | 88.78 |
| PEG Ratio | 0.54 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 90.73, with an EV/FCF ratio of 108.62.
| EV / Earnings | 81.15 |
| EV / Sales | 24.06 |
| EV / EBITDA | 90.73 |
| EV / EBIT | 94.28 |
| EV / FCF | 108.62 |
Financial Position
The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.03 |
| Quick Ratio | 7.04 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 28.21% and return on invested capital (ROIC) is 67.11%.
| Return on Equity (ROE) | 28.21% |
| Return on Assets (ROA) | 13.41% |
| Return on Invested Capital (ROIC) | 67.11% |
| Return on Capital Employed (ROCE) | 19.31% |
| Weighted Average Cost of Capital (WACC) | 25.45% |
| Revenue Per Employee | $2.06M |
| Profits Per Employee | $610,217 |
| Employee Count | 756 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 3.22 |
Taxes
| Income Tax | -14.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.59% in the last 52 weeks. The beta is 3.86, so Astera Labs's price volatility has been higher than the market average.
| Beta (5Y) | 3.86 |
| 52-Week Price Change | +40.59% |
| 50-Day Moving Average | 294.27 |
| 200-Day Moving Average | 257.46 |
| Relative Strength Index (RSI) | 39.81 |
| Average Volume (20 Days) | 4,927,000 |
Short Selling Information
The latest short interest is 7.95 million, so 4.55% of the outstanding shares have been sold short.
| Short Interest | 7.95M |
| Short Previous Month | 8.02M |
| Short % of Shares Out | 4.55% |
| Short % of Float | 5.06% |
| Short Ratio (days to cover) | 1.94 |
Income Statement
In the last 12 months, Astera Labs had revenue of $1.56 billion and earned $461.32 million in profits. Earnings per share was $2.53.
| Revenue | 1.56B |
| Gross Profit | 1.15B |
| Operating Income | 397.10M |
| Pretax Income | 447.18M |
| Net Income | 461.32M |
| EBITDA | 412.62M |
| EBIT | 397.10M |
| Earnings Per Share (EPS) | $2.53 |
Balance Sheet
The company has $1.38 billion in cash and $44.99 million in debt, with a net cash position of $1.33 billion or $7.63 per share.
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 44.99M |
| Net Cash | 1.33B |
| Net Cash Per Share | $7.63 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 11.44 |
| Working Capital | 1.71B |
Cash Flow
In the last 12 months, operating cash flow was $436.74 million and capital expenditures -$92.05 million, giving a free cash flow of $344.69 million.
| Operating Cash Flow | 436.74M |
| Capital Expenditures | -92.05M |
| Depreciation & Amortization | 15.53M |
| Net Borrowing | n/a |
| Free Cash Flow | 344.69M |
| FCF Per Share | $1.97 |
Margins
Gross margin is 73.89%, with operating and profit margins of 25.52% and 29.64%.
| Gross Margin | 73.89% |
| Operating Margin | 25.52% |
| Pretax Margin | 28.73% |
| Profit Margin | 29.64% |
| EBITDA Margin | 26.51% |
| EBIT Margin | 25.52% |
| FCF Margin | 22.15% |
Dividends & Yields
Astera Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | 1.14% |
| FCF Yield | 0.89% |
Analyst Forecast
The average price target for Astera Labs is $344.15, which is 55.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $344.15 |
| Price Target Difference | 55.14% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 72.25% |
| EPS Growth Forecast (3Y) | 68.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astera Labs has an Altman Z-Score of 79.02 and a Piotroski F-Score of 4.
| Altman Z-Score | 79.02 |
| Piotroski F-Score | 4 |